Unknown

Dataset Information

0

Parallel reductions of IgE and exhaled nitric oxide after optimized anti-inflammatory asthma treatment.


ABSTRACT: Immunoglobulin E (IgE) is crucial for the development of airway inflammation in atopic asthma, and inhibition of IgE using monoclonal antibodies is now part of asthma therapy. However, the impact of ordinary anti-inflammatory treatment on IgE is unclear. The aim of this study was to investigate if optimization of treatment with inhaled corticosteroid (ICS) and leukotriene-receptor antagonist (LTRA) according to symptoms or exhaled nitric oxide (FENO) levels over a one-year period affects IgE concentrations. Altogether, 158 relatively well-controlled but multi-sensitized asthmatics (age 18-65 years), with ongoing ICS treatment at baseline, were included in this post hoc analysis of data from a randomized, controlled trial on FENO-guided asthma therapy. Asthma control and quality of life (Juniper ACQ and mAQLQ), FENO, and serum IgE were measured at baseline and after one year. Concentrations of IgE antibodies to six common perennial aeroallergens were summed up (perennial IgE). We found that perennial and total IgE decreased by 10.2% and 16.0% (P?

SUBMITTER: Syk J 

PROVIDER: S-EPMC4879464 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Parallel reductions of IgE and exhaled nitric oxide after optimized anti-inflammatory asthma treatment.

Syk Jörgen J   Malinovschi Andrei A   Borres Magnus P MP   Undén Anna-Lena AL   Andreasson Anna A   Lekander Mats M   Alving Kjell K  

Immunity, inflammation and disease 20160321 2


Immunoglobulin E (IgE) is crucial for the development of airway inflammation in atopic asthma, and inhibition of IgE using monoclonal antibodies is now part of asthma therapy. However, the impact of ordinary anti-inflammatory treatment on IgE is unclear. The aim of this study was to investigate if optimization of treatment with inhaled corticosteroid (ICS) and leukotriene-receptor antagonist (LTRA) according to symptoms or exhaled nitric oxide (F<sub>E</sub>NO) levels over a one-year period affe  ...[more]

Similar Datasets

| S-EPMC8248142 | biostudies-literature
| S-EPMC3172885 | biostudies-literature
| S-EPMC4020940 | biostudies-literature
| S-EPMC3778731 | biostudies-literature
| S-EPMC2935914 | biostudies-literature
| S-EPMC3938593 | biostudies-literature
| S-EPMC5047770 | biostudies-literature
| S-EPMC3748140 | biostudies-literature
| S-EPMC3348876 | biostudies-literature